In vitro platelet abnormality in adenosine deaminase deficiency and severe combined immunodeficiency. 1979

C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden

The platelets of an infant with severe combined immune deficiency and adenosine deaminase deficiency showed markedly diminished responses to ADP-induced aggregation in vitro. This abnormality was corrected by the addition of purified adenosine deaminase in vitro. Exogenous adenosine added to platelet-rich plasma caused markedly prolonged inhibition of ADP-induced aggregation. This was shown by isotopic studies to be due to slow clearance of adenosine and hence persistence of this nucleoside. Direct assay for adenosine deaminiase in plasma and platelet lysates of the patient confirmed the very low activity of this enzyme. Raised cAMP levels were demonstrated in his platelets. The deranged adenosine metabolism and raised cAMP in the platelets of this child with severe combined immunodeficiency may explain the altered response to ADP. Despite the in vitro platelet aggregation abnormality, the patient had no clinical evidence of impaired hemostasis.

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001791 Blood Platelet Disorders Disorders caused by abnormalities in platelet count or function. Thrombocytopathy,Blood Platelet Disorder,Disorder, Blood Platelet,Disorders, Blood Platelet,Platelet Disorder, Blood,Platelet Disorders, Blood,Thrombocytopathies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine

Related Publications

C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
February 1980, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
April 1975, The New England journal of medicine,
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
June 1978, British journal of haematology,
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
January 1980, Advances in enzymology and related areas of molecular biology,
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
May 1977, Life sciences,
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
November 1973, Lancet (London, England),
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
June 1973, Lancet (London, England),
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
March 2012, JPMA. The Journal of the Pakistan Medical Association,
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
October 1979, The Tohoku journal of experimental medicine,
C H Lee, and S P Evans, and M C Rozenberg, and A S Bagnara, and J B Ziegler, and M B Van der Weyden
May 1982, Anales espanoles de pediatria,
Copied contents to your clipboard!